Healthcare • Drug Manufacturers - Specialty & Generic
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if BGM is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
4 top institutions tracked
Sentiment: unknown
No recent insider trades detected.
Red flags: 0
12 filers reported a long position in BGM for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | $36.2K | 98.5K | +109.7% |
| XTX Topco Ltd | $23.2K | 63.1K | +451.6% |
| UBS Group AG | $21.2K | 57.6K | +2,853.2% |
| JANE STREET GROUP, LLC | $21K | 57.2K | New |
| Virtu Financial LLC | $20K | 54.2K | New |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $11.8K | 32.1K | +103.8% |
| Ground Swell Capital, LLC | $4.1K | 11.1K | New |
| ROYAL BANK OF CANADA | $1K | 1.5K | -25.3% |
| JPMORGAN CHASE & CO | $681 | 1.8K | -8.5% |
| MORGAN STANLEY | $74 | 200 | Unchanged |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.